Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Branford · SciRah

Researcher profile · Semantic Scholar

S. Branford

Share profile

S. Branford — researcher profile on SciRah

h-index: 58
Works: 322
Citations: 21K

Most-cited papers

International Consensus Classification of Myeloid Neoplasms and Acute Leukemia: Integrating Morphological, Clinical, and Genomic Data.
D. Arber, A. Orazi, R. Hasserjian, M. Borowitz +64 more
2022Blood2,571 citations Open access
Semantic Scholar
Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease.
S. Branford, Paul P. S. Wang, D. Yeung, D. Thomson +29 more
2018Blood192 citations Open access
Semantic Scholar
Genomic Profiling for Clinical Decision Making in Myeloid Neoplasms and Acute Leukemia.
E. Duncavage, A. Bagg, R. Hasserjian, C. Dinardo +40 more
2022Blood186 citations Open access
Semantic Scholar
Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia
S. Branford, D. Kim, J. Apperley, C. Eide +14 more
2019Leukemia129 citations Open access
Semantic Scholar
European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia
N. Cross, Thomas Ernst, S. Branford, J. Cayuela +9 more
2023Leukemia118 citations Open access
Semantic Scholar
Early BCR-ABL1 kinetics are predictive of subsequent achievement of treatment-free remission in chronic myeloid leukemia.
N. Shanmuganathan, I. Pagani, D. Ross, Sahee Park +8 more
2020Blood86 citations Open access
Semantic Scholar
Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia
Y. Ochi, K. Yoshida, Ying-Jung Huang, Ming-Chung Kuo +31 more
2021Nature Communications85 citations Open access
Semantic Scholar
Standardized practices for RNA diagnostics using clinically accessible specimens reclassifies 75% of putative splicing variants.
A. Bournazos, L. Riley, Shobhana Bommireddipalli, L. Adès +212 more
2021Genetics in Medicine85 citations Open access
Semantic Scholar
RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses
Shady Adnan Awad, O. Dufva, A. Ianevski, B. Ghimire +12 more
2020Leukemia59 citations Open access
Semantic Scholar
The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution
D. Singhal, Yan-Wee A. Li, M. Kutyna, R. Chhetri +23 more
2019Leukemia56 citations
Semantic Scholar
Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remission
I. Pagani, P. Dang, V. Saunders, R. Grose +14 more
2019Leukemia43 citations
Semantic Scholar
Aberrant RAG-mediated recombination contributes to multiple structural rearrangements in lymphoid blast crisis of chronic myeloid leukemia
D. Thomson, N. Shahrin, Paul P. S. Wang, C. Wadham +6 more
2020Leukemia41 citations
Semantic Scholar
Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention
N. Shanmuganathan, C. Wadham, N. Shahrin, Jing-Hua Feng +20 more
2023Haematologica39 citations Open access
Semantic Scholar
BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia
I. Pagani, P. Dang, Ivar O. Kommers, J. Goyne +8 more
2018Haematologica33 citations Open access
Semantic Scholar
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways
V. Magistroni, Mario Mauri, D. D’Aliberti, C. Mezzatesta +24 more
2019Haematologica31 citations Open access
Semantic Scholar
Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation
Shady Adnan Awad, O. Brück, N. Shanmuganathan, Timo Jarvinen +9 more
2022Blood Cancer Journal29 citations Open access
Semantic Scholar
Asciminib Monotherapy as Frontline Treatment of Chronic-Phase Chronic Myeloid Leukemia: Results from the ASCEND Study.
David T. Yeung, N. Shanmuganathan, John Reynolds, S. Branford +17 more
2024Blood26 citations
Semantic Scholar
Why is it critical to achieve a deep molecular response in chronic myeloid leukemia?
S. Branford
2020Haematologica26 citations Open access
Semantic Scholar
Modelling the safe minimum frequency of molecular monitoring for CML patients attempting treatment-free remission.
N. Shanmuganathan, Jodi A. Braley, A. Yong, D. Hiwase +4 more
2019Blood26 citations Open access
Semantic Scholar
The effect of tyrosine kinase inhibitor interruption and interferon use on pregnancy outcomes and long-term disease control in chronic myeloid leukemia
M. Lasica, A. Willcox, K. Burbury, D. Ross +12 more
2019Leukemia and Lymphoma24 citations
Semantic Scholar
Integrating genetic and epigenetic factors in chronic myeloid leukemia risk assessment: toward gene expression-based biomarkers
V. Krishnan, D. Kim, T. Hughes, S. Branford +1 more
2021Haematologica22 citations Open access
Semantic Scholar
Genomic Mechanisms Influencing Outcome in Chronic Myeloid Leukemia
A. Fernandes, N. Shanmuganathan, S. Branford
2022Cancers20 citations Open access
Semantic Scholar
Association of TIM-3 checkpoint receptor expression on T cells with treatment-free remission in chronic myeloid leukemia
Y. Irani, C. Kok, J. Clarson, N. Shanmuganathan +5 more
2023Blood Advances19 citations Open access
Semantic Scholar
Measurable residual disease in chronic myeloid leukemia
S. Branford, J. Apperley
2022Haematologica19 citations Open access
Semantic Scholar
Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations.
N. Shanmuganathan, D. Yeung, C. Wadham, A. Fernandes +17 more
2025Blood18 citations
Semantic Scholar
IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation
Lih-En Hong, M. Wechalekar, M. Kutyna, A. Small +20 more
2024Blood17 citations Open access
Semantic Scholar
Are There New Relevant Therapeutic Endpoints in the Modern Era of the BCR::ABL1 Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia?
H. Kantarjian, S. Branford, Massimo Breccia, Jorge E. Cortes +8 more
2024Leukemia16 citations
Semantic Scholar
Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition
Jiarna R. Zerella, Claire C. Homan, P. Arts, Xuzhu Lin +49 more
2024Blood14 citations Open access
Semantic Scholar
The e13a2 BCR-ABL1 Transcript Is Associated with Higher Rates of Molecular Recurrence after Treatment-Free Remission Attempts: Retrospective Analysis of the Adelaide Cohort
N. Shanmuganathan, S. Branford, A. Yong, D. Hiwase +3 more
2018Blood14 citations Open access
Semantic Scholar
Beyond BCR::ABL1-The Role of Genomic Analyses in the Management of CML.
S. Branford, A. Fernandes, N. Shahrin, Muneeza Maqsood +2 more
2024The Journal of the National Comprehensive Cancer Network13 citations Open access
Semantic Scholar
Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia
D. Ross, I. Pagani, Y. Irani, J. Clarson +11 more
2019British Journal of Haematology13 citations Open access
Semantic Scholar
Widespread Aberrant Alternative Splicing despite Molecular Remission in Chronic Myeloid Leukaemia Patients
U. Schmitz, J. Shah, Bijay P. Dhungel, Geoffray Monteuuis +13 more
2020medRxiv12 citations Open access
Semantic Scholar
Strong Association between Cancer Gene Variants at Diagnosis, Especially ASXL1, and Emergence of Kinase Domain Mutation-Driven Resistance in CML Patients Despite Frontline Treatment with More Potent BCR::ABL1 Inhibitors
N. Shanmuganathan, C. Wadham, David T. Yeung, N. Shahrin +10 more
2024Blood11 citations
Semantic Scholar
BCR::ABL1 digital PCR for treatment‐free remission prediction in chronic myeloid leukemia patients: An individual participant data meta‐analysis
Camille Kockerols, P. Valk, S. Dulucq, F. Nicolini +19 more
2024American journal of hematology/oncology11 citations Open access
Semantic Scholar
Lineage-specific detection of residual disease predicts relapse in chronic myeloid leukemia patients stopping therapy.
I. Pagani, N. Shanmuganathan, P. Dang, V. Saunders +11 more
2023Blood10 citations
Semantic Scholar
Clinical utility of genomic DNA Q-PCR for the monitoring of a patient with atypical e19a2 BCR-ABL1 transcripts in chronic myeloid leukemia
I. Pagani, P. Dang, V. Saunders, Jodi A. Braley +4 more
2020Leukemia and Lymphoma10 citations
Semantic Scholar
The Hidden Pathogenesis of CML: Is BCR-ABL1 the First Event?
N. Shanmuganathan, S. Branford
2019Current Hematologic Malignancy Reports10 citations
Semantic Scholar
Bone marrow fibrosis associated with long-term imatinib therapy: resolution after switching to a second-generation TKI.
N. Shanmuganathan, S. Branford, T. Hughes, D. Hiwase
2019Blood Advances9 citations Open access
Semantic Scholar
RNA-based targeted gene sequencing improves the diagnostic yield of mutant detection in chronic myeloid leukemia.
N. Shanmuganathan, C. Wadham, D. Thomson, N. Shahrin +16 more
2022Journal of Molecular Diagnostics8 citations Open access
Semantic Scholar
Defining Higher-Risk Chronic Myeloid Leukemia: Risk Scores, Genomic Landscape, and Prognostication
N. Shahrin, C. Wadham, S. Branford
2022Current Hematologic Malignancy Reports8 citations Open access
Semantic Scholar
Chronic myeloid leukaemia: The dangers of not knowing your BCR-ABL1 transcript.
Kirsty Sharplin, Haley K Altamura, K. Taylor, J. Wellwood +2 more
2019Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis8 citations
Semantic Scholar
Update of the Ascend-CML Study of Frontline Asciminib: High Rate of Optimal Response and Resistance Due to Mutations Is Rare
David T. Yeung, N. Shanmuganathan, Agnes S. M. Yong, J. Shortt +17 more
2024Blood7 citations
Semantic Scholar
Age-Related Clonal Hematopoiesis Mutations Detected at the Time of Stopping Tyrosine Kinase Inhibitor Therapy Predict the Achievement of Treatment-Free Remission for Patients with CML
S. Branford, C. Wadham, N. Shanmuganathan, A. Fernandes +15 more
2023Blood7 citations
Semantic Scholar
Molecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modeling and pathway analysis
J. Radich, Matthew A. Wall, S. Branford, C. Campbell +19 more
2023Haematologica7 citations Open access
Semantic Scholar
Highly sensitive droplet digital polymerase chain reaction for BCR::ABL1 messenger RNA identifies patients with chronic myeloid leukaemia with a low probability of achieving treatment‐free remission
Liu Lu, C. Kok, P. Dang, S. Branford +5 more
2022British Journal of Haematology7 citations
Semantic Scholar
NGS in CML - New standard diagnostic procedure?
S. Branford, N. Shanmuganathan
2019HemaSphere7 citations Open access
Semantic Scholar
Immune modulation in chronic myeloid leukaemia patients treated with nilotinib and interferon‐alpha
Y. Irani, Amy Hughes, C. Kok, J. Clarson +5 more
2023British Journal of Haematology6 citations Open access
Semantic Scholar
Impact of Mutations in Blood Cancer-Related Genes on Clinical Outcomes in Chronic Myeloid Leukemia in Chronic Phase (CML-CP) after ≥2 Tyrosine Kinase Inhibitors (TKIs) in the Ascembl Trial
S. Branford, A. Hochhaus, M. Mauro, Yosuke Minami +7 more
2023Blood5 citations Open access
Semantic Scholar
Excellent Early and Major Molecular Responses Observed with Asciminib Treatment for CP-CML: Results from the ALLG CML13 Ascend-CML Study
David T. Yeung, N. Shanmuganathan, J. Reynolds, S. Branford +19 more
2023Blood5 citations Open access
Semantic Scholar
Gene Expression Signature Predicts Deep Molecular Response (DMR) in Chronic Myeloid Leukemia (CML): An Exploratory Biomarker Analysis from ENESTnd
J. Radich, R. Larson, H. Kantarjian, M. Deininger +13 more
2019Blood5 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Shanmuganathan×24
Invite
N. Shanmuganathan — researcher profile on SciRah
D. Ross×14
Invite
D. Ross — researcher profile on SciRah
T. Hughes×14
Invite
T. Hughes — researcher profile on SciRah
D. Yeung×13
Invite
D. Yeung — researcher profile on SciRah

×12

Invite

V. Saunders — researcher profile on SciRah

Invite

T. Hughes — researcher profile on SciRah

Invite

C. Kok — researcher profile on SciRah

Invite

A. Yong — researcher profile on SciRah

Invite

C. Wadham — researcher profile on SciRah

Invite

N. Shahrin — researcher profile on SciRah

Jodi A. Braley×9

Invite

Jodi A. Braley — researcher profile on SciRah

Invite

I. Pagani — researcher profile on SciRah